Brett D Lindenbach

Title: Brett D. Lindenbach: Innovator in Hepatitis C Research

Introduction

Brett D. Lindenbach is a prominent inventor based in New York, NY (US). He is known for his significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). His innovative work has led to advancements in understanding and combating this infectious disease.

Latest Patents

Brett D. Lindenbach holds a patent for an "Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof." This invention provides infectious recombinant Hepatitis C Viruses (HCV), along with vectors, cells, and animals that comprise the same. The patent outlines methods for producing infectious recombinant HCV and their applications in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis. He has 1 patent to his name.

Career Highlights

Brett D. Lindenbach is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing the understanding of hepatitis C and developing potential therapeutic strategies.

Collaborations

Brett has collaborated with notable colleagues in his field, including Christopher G. Jones and Charles Moen Rice, III. These collaborations have further enriched his research and contributed to the scientific community's knowledge of HCV.

Conclusion

Brett D. Lindenbach's innovative research and patent contributions have made a significant impact in the field of hepatitis C research. His work continues to pave the way for future advancements in the fight against this infectious disease.